Retrospective Review of Exceptions for Angiotensin-Converting Enzyme Inhibitor or Angiotensin II Receptor Blocker Recommendations for a Diabetic Medicare Population

Retrospective Review ◽

Enzyme Inhibitor ◽

Receptor Blocker ◽

Converting Enzyme ◽

Angiotensin Ii Receptor ◽

Correction: Angiotensin II receptor blocker or angiotensin-converting enzyme inhibitor use and COVID-19-related outcomes among US Veterans

PLoS ONE ◽

10.1371/journal.pone.0251897 ◽

2021 ◽

Vol 16 (5) ◽

pp. e0251897

Author(s):

Keyword(s):

Angiotensin Ii ◽

Enzyme Inhibitor ◽

Receptor Blocker ◽

Converting Enzyme ◽

Angiotensin Ii Receptor ◽

Converting Enzyme Inhibitor ◽

Us Veterans

Angiotensin Converting Enzyme Inhibitor and Angiotensin II Receptor Blocker Use Among Outpatients Diagnosed With COVID-19

The American Journal of Cardiology ◽

10.1016/j.amjcard.2020.07.007 ◽

2020 ◽

Vol 132 ◽

pp. 150-157 ◽

Cited By ~ 4

Author(s):

David J. Bae ◽

David M. Tehrani ◽

Soniya V. Rabadia ◽

Marlene Frost ◽

Rushi V. Parikh ◽

...

Keyword(s):

Angiotensin Ii ◽

Enzyme Inhibitor ◽

Receptor Blocker ◽

Converting Enzyme ◽

Angiotensin Ii Receptor ◽

Faculty Opinions recommendation of Angiotensin Converting Enzyme Inhibitor and Angiotensin II Receptor Blocker Use Among Outpatients Diagnosed With COVID-19.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.738373819.793579719 ◽

2020 ◽

Author(s):

Wilbert Aronow

Keyword(s):

Angiotensin Ii ◽

Enzyme Inhibitor ◽

Receptor Blocker ◽

Converting Enzyme ◽

Angiotensin Ii Receptor ◽

Effect of angiotensin converting enzyme inhibitor and angiotensin II receptor blocker on the patients with sepsis

The Korean Journal of Internal Medicine ◽

10.3904/kjim.2019.262 ◽

2020 ◽

Author(s):

Hyun Woo Lee ◽

Jae Kyung Suh ◽

Eunjin Jang ◽

Sang-Min Lee

Keyword(s):

Angiotensin Ii ◽

Enzyme Inhibitor ◽

Receptor Blocker ◽

Converting Enzyme ◽

Angiotensin Ii Receptor ◽

Trends in the Use of Angiotensin-Converting Enzyme Inhibitor and Angiotensin-II Receptor Blocker Among United States Adults From 1999 to 2018

Endocrine Practice ◽

10.1016/j.eprac.2020.12.008 ◽

2021 ◽

Vol 27 (5) ◽

pp. 503-504

Author(s):

Kosuke Inoue ◽

Colette DeJong ◽

Masaomi Nangaku

Keyword(s):

United States ◽

Angiotensin Ii ◽

Enzyme Inhibitor ◽

Receptor Blocker ◽

Converting Enzyme ◽

Angiotensin Ii Receptor ◽

Faculty Opinions recommendation of Angiotensin Converting Enzyme Inhibitor and Angiotensin II Receptor Blocker Use Among Outpatients Diagnosed with COVID-19.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.738373819.793576927 ◽

2020 ◽

Author(s):

Ehab Farag

Keyword(s):

Angiotensin Ii ◽

Enzyme Inhibitor ◽

Receptor Blocker ◽

Converting Enzyme ◽

Angiotensin Ii Receptor ◽

Review: Angiotensin II receptor blocker plus angiotensin-converting enzyme inhibitor increases risk for adverse effects

ACP Journal Club ◽

10.7326/acpjc-2008-148-2-035 ◽

2008 ◽

Vol 148 (2) ◽

pp. 35

Author(s):

Christopher B. Granger

Keyword(s):

Angiotensin Ii ◽

Adverse Effects ◽

Enzyme Inhibitor ◽

Receptor Blocker ◽

Converting Enzyme ◽

Angiotensin Ii Receptor ◽

Effects of Angiotensin Converting Enzyme Inhibitor and Angiotensin II Receptor Blocker on Ventricular Defibrillation Threshold

Pacing and Clinical Electrophysiology ◽

10.1111/j.1540-8159.2006.00429.x ◽

2006 ◽

Vol 29 (7) ◽

pp. 747-752 ◽

Cited By ~ 2

Author(s):

HIDEYUKI KAMOCHI ◽

YOSHIO YAMANOUCHI ◽

KEIJIRO SAKU

Keyword(s):

Angiotensin Ii ◽

Enzyme Inhibitor ◽

Receptor Blocker ◽

Converting Enzyme ◽

Defibrillation Threshold ◽

Angiotensin Ii Receptor ◽

Clinical evidence from ONTARGET: the value of an angiotensin II receptor blocker and an angiotensin-converting enzyme inhibitor

Journal of Hypertension ◽

10.1097/01.hjh.0000357905.78704.9a ◽

2009 ◽

Vol 27 (Suppl 5) ◽

pp. S23-S29 ◽

Cited By ~ 9

Author(s):

Peter Sleight

Keyword(s):

Angiotensin Ii ◽

Clinical Evidence ◽

Enzyme Inhibitor ◽

Receptor Blocker ◽

Converting Enzyme ◽

Angiotensin Ii Receptor ◽

Do Captopril Renogram and Losartan Renogram Influence the Choice of Drug (Angiotensin Converting Enzyme Inhibitor/Angiotensin II Receptor Blocker) to be Initiated in Renal Patients?

Hong Kong Journal of Nephrology ◽

10.1016/s1561-5413(09)60234-9 ◽

2006 ◽

Vol 8 (2) ◽

pp. 61-67

Author(s):

R. Ram ◽

K.V. Dakshinamurty ◽

Neela Prasad ◽

Pushpalatha Sudhakar

Keyword(s):

Angiotensin Ii ◽

Enzyme Inhibitor ◽

Receptor Blocker ◽

Converting Enzyme ◽

Angiotensin Ii Receptor ◽